Pharmacotherapy and Lung Function Decline in Patients with Chronic Obstructive Pulmonary Disease. A Systematic Review

Rationale: Whether pharmacological therapy alters decline in FEV(1) in chronic obstructive pulmonary disease remains controversial. Because pharmacotherapy improves health status, exacerbation rate, and symptoms, it may be unethical to complete placebo-controlled long-term studies aimed at modifying...

Descripción completa

Detalles Bibliográficos
Autores principales: Celli, Bartolome R., Anderson, Julie A., Cowans, Nicholas J., Crim, Courtney, Hartley, Benjamin F., Martinez, Fernando J., Morris, Andrea N., Quasny, Holly, Yates, Julie, Vestbo, Jørgen, Calverley, Peter M. A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Thoracic Society 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7958521/
https://www.ncbi.nlm.nih.gov/pubmed/32966751
http://dx.doi.org/10.1164/rccm.202005-1854OC

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7958521/
https://www.ncbi.nlm.nih.gov/pubmed/32966751
http://dx.doi.org/10.1164/rccm.202005-1854OC

Ejemplares similares